| 112.20 |  -5.57 / -4.73% |
Data as of Jun 05 | Day’s Change |
| 113.80 |  +1.60 / +1.43% |
Volume: 6.6K |
| 'Mad Money' Lightning Round: Amgen's Not a Fave 6:06am / TheStreet.com | Cramer's 'Mad Money' Recap: Out With the New Jun 03 / TheStreet.com |
| Today's 3 Worst Stocks Jun 05 / MotleyFool.com | CHMP Backs Celgene's Pomalyst - Analyst Blog Jun 03 / Zacks.com |
| Celgene Presents Data at ASCO - Analyst Blog Jun 05 / Zacks.com | Gilead's Stribild Approved in the EU - Analyst Blog May 29 / Zacks.com |
| Celgene Corporation (CELG): Today's Featured Health Care Laggard Jun 04 / TheStreet.com | Encouraging Data from Alkermes - Analyst Blog May 29 / Zacks.com |
| CELG, AMGN, GILD, JNJ And PFE, Pushing Drugs Industry Downward Jun 04 / TheStreet.com | Pfizer Aims to Give up Remaining Zoetis Stake - Analyst Blog May 28 / Zacks.com |
| Previous close | 117.77 |
| Today’s open | 117.03 |
| Day’s range | -- - -- |
| Volume | 5,312,179 |
| Average volume (3 months) | 3,160,031 |
| Market cap | $46.8B |
| Dividend yield | -- |
| Earnings growth (last year) | +15.79% |
| Earnings growth (this year) | +16.59% |
| Earnings growth (next 5 years) | +22.00% |
| Revenue growth (last year) | +12.05% |
| P/E ratio | 34.1 |
| Price/Sales | 6.23 |
| Price/Book | 8.27 |
| Today’s change | Today’s % change | |
|---|---|---|
| ABTAbbott Laboratories | -0.50 | -1.36% |
| LLYEli Lilly and Co | -0.69 | -1.31% |
| AZNAstraZeneca PLC | -0.45 | -0.88% |
| AGNAllergan Inc | -1.22 | -1.24% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $1.43 |
| Annual revenue (last year) | $5.4B |
| Annual profit (last year) | $1.5B |
| Net profit margin | 26.84% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Robert J. Hugin, MBA |
Chief Operating Officer & Executive Vice President Perry A. Karsen |
Corporate headquarters Summit, New Jersey |
.
